Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
24.17
+0.20 (0.86%)
At close: Oct 28, 2025, 4:00 PM EDT
24.15
-0.02 (-0.06%)
After-hours: Oct 28, 2025, 4:29 PM EDT
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $700.55 million as of October 28, 2025. Its market cap has decreased by -10.75% in one year.
Market Cap
700.55M
Enterprise Value
461.97M
1-Year Change
-10.75%
Ranking
Category
Stock Price
$24.17
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $700.55M, an increase of 469.32%. That is a compound annual growth rate of 32.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 695.04M | -6.88% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | 1.62B | 176.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |